NCT05281198

Brief Summary

The purpose of this study is to determine whether tart cherry supplementation effects thermotolerance and heat acclimation in human subjects exposed to exercise/heat stress. Specific Aim I. To determine if tart cherry in combination with repeated bouts of thermally stressful exercise will impact the gut microbiome \& inflammation measured via stool sample \& blood samples for plasma endotoxin, inflammatory cytokines and HSP. Specific Aim II. To determine whether whole body hyperthermia causes changes in bacterial populations in the gut microbiome, and if these changes are affected by washout or re-acclimation. Specific Aim III. To determine whether tart cherry supplementation suppresses the ability of human subjects to acclimate to exercise/heat stress. This will be assessed via body temperature, heart rate, sweat and plasma volume responses, and exercise performance during standardized heat tolerance tests.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2022

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

February 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

October 16, 2023

Status Verified

October 1, 2023

Enrollment Period

1.3 years

First QC Date

February 14, 2022

Last Update Submit

October 12, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • Change in Plasma TNF-a

    Plasma TNF-a changes from pre to 1 hour post heat tolerance test

    pre, 1 hour post heat tolerance test

  • Change in Plasma IL-6

    Plasma IL-6 changes from pre to 1 hour post heat tolerance test

    pre, 1 hour post heat tolerance test

  • Change in Plasma HSP70

    Plasma HSP70 changes from pre to 1 hour post heat tolerance test

    pre, 1 hour post heat tolerance test

  • Change in Plasma melatonin content

    Plasma melatonin content from pre to post supplementation

    pre- heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

  • Change in Core temperature response to heat tolerance test

    Core temperature response to heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress

    heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

  • Change in Skin temperature response to heat tolerance test

    Skin temperature response to heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress

    heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

  • Change in Mean body temperature response to heat tolerance test

    Mean body temperature response to heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress

    heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

  • Change in Heart rate response to heat tolerance test

    Heart rate response to heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress

    heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

  • Change in Physiological strain response to heat tolerance test

    Physiological strain response to heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress

    heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

  • Change in gut microbial content

    Gut microbial content from pre to post supplementation

    pre- heat tolerance test 1 (before study onset) and 2 (day 6 of exercise/heat stress)

Study Arms (2)

Experimental: tart cherry

EXPERIMENTAL

dietary supplement: tart cherry juice

Dietary Supplement: tart cherry juice

Placebo

PLACEBO COMPARATOR

dietary supplement: placebo juice

Dietary Supplement: Placebo

Interventions

tart cherry juiceDIETARY_SUPPLEMENT

2, 8oz bottles of Montmorency tart cherry juice daily; 8oz taken in AM, 8oz taken in PM

Experimental: tart cherry
PlaceboDIETARY_SUPPLEMENT

2, 8oz bottles of placebo juice daily; 8oz taken in AM, 8oz taken in PM

Placebo

Eligibility Criteria

Age18 Years - 55 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • years old
  • Recreational cyclists (\>150 minutes per week of cycling exercise)
  • VO2max \>60th percentile according to ACSM

You may not qualify if:

  • Previous episode of heat illness, such as heat syncope, heat exhaustion or heat stroke
  • Known cardiopulmonary disease, metabolic disorders, Parkinsons Disease, or multiple sclerosis or other autonomic nervous system conditions
  • diagnosed with or being treated for arthritis or any inflammatory condition (such as Lupus, gout, or Sjogrens syndrome)
  • Known or suspected orthostatic hypotension or low blood pressure
  • Known issues with cooling or sweating
  • currently smoke or quit smoking less than one year ago
  • not willing to self-insert a flexible, thin (3 mm) vinyl rectal probe and maintain this position throughout all exercise sessions.
  • not willing to have blood drawn pre-supplementation and 4 times during heat stress test trials (a total of 10 times during the study).
  • not willing to provide a stool sample pre- and post-heat stress tests (4 total samples).
  • allergy to cherries or food dyes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio University Exercise Physiology Lab

Athens, Ohio, 45701, United States

Location

Study Officials

  • Angela Hillman, PhD

    Division of Exercise Physiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2022

First Posted

March 16, 2022

Study Start

January 26, 2022

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

October 16, 2023

Record last verified: 2023-10

Locations